MTP
Desconocido
MIRCAB: Validation of diagnostic and or prognostic miRNAs in triple negative breast cancer
MULTIPLICOM NV
tramitó un
H2020:
H2020-SMEInst-2014-2015
Multiplicom will draft a business plan that is composed of the following parts:
(i) selection of miRNAs for which there is substantial scien...
2015-01-13 - 2015-06-30 | Financiado
2015-01-13 - 2015-06-30 | Financiado
EUROSTAM: A Europe wide Strategy to enhance Transplantation of highly sensitized patients on basis of Acceptab...
MULTIPLICOM NV
participó en un
FP7:
The presence of donor specific HLA antibodies is a contra-indication for renal transplantation. Highly sensitized patients accumulate and of...
Financiado
Financiado
EURENOMICS: European Consortium for High Throughput Research in Rare Kidney Diseases
MULTIPLICOM NV
participó en un
FP7:
EURenOmics will integrate several established consortia devoted to rare kidney diseases with eminent need and potential for diagnostic and t...
Financiado
Financiado
BESTAGEING: Biomarker Research Alliance for Diagnosing Heart Disease in the Ageing European Population
MULTIPLICOM NV
participó en un
FP7:
The ageing of the European population represents a rapidly rising social and economic challenge. Especially cardiovascular morbidity increas...
Financiado
Financiado
* No se disponen de datos de la empresa actual.